Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

MLA

Federica Miglietta, et al. Chemotherapy for Advanced HER2-Negative Breast Cancer: Can One Algorithm Fit All? Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....964df70a0a0ec1f96f43619803285231&authtype=sso&custid=ns315887.

APA

Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Maria Vittoria Dieci, & Pierfranco Conte. (2017). Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

Chicago

Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Maria Vittoria Dieci, and Pierfranco Conte. 2017. “Chemotherapy for Advanced HER2-Negative Breast Cancer: Can One Algorithm Fit All?,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....964df70a0a0ec1f96f43619803285231&authtype=sso&custid=ns315887.